GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.20
Tradestie Score
53
Market Cap
$899.60M
Revenue Growth
0.2%
Analyst Upside
+254.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GHRS
GH Research PLC Ordinary Shares
|
$22.94
|
$841.74M | - | 55 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$94.45
|
$832.47M | - | 36 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$41.40
|
$824.20M | - | 67 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.56
|
$821.84M | - | 58 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$58.51
|
$800.41M | - | 57 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$14.22
|
$799.70M | - | 36 | Compare |
|
KURA
Kura Oncology, Inc.
|
$10.65
|
$798.53M | - | 61 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$11.17
|
$791.82M | - | 48 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$8.23
|
$757.72M | - | 45 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$28.27
|
$748.90M | - | 56 | Compare |
More GERN Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry